Original Research

Published on 03 Jul 2024

Potential value and research frontiers of virus in neuroinflammation: a bibliometric and visualized analysis

in Multiple Sclerosis and Neuroimmunology

Danyang Li
Minghua Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1390149

2,248 views
1 citation

Case Report

Published on 03 Jul 2024

Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers

in Multiple Sclerosis and Neuroimmunology

Neus Rabaneda-Lombarte
Aina Teniente-Serra
Anna Massuet-Vilamajó
Cristina Ramo-Tello
Silvia Presas-Rodríguez

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395749

934 views
1 citation

Original Research

Published on 02 Jul 2024

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)

in Multiple Sclerosis and Neuroimmunology

Sara Samadzadeh
Rafl Adnan
Paulina Berglova
Mahdi Barzegar
Birgit Debrabant
Stine Gundtoft Roikjaer
Michael Levy
Axel Petzold
Jacqueline Palace
Eoin P. Flanagan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380025

3,142 views

Original Research

Published on 01 Jul 2024

The levels of circulating cytokines and risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study

in Multiple Sclerosis and Neuroimmunology

Xue Ma
Yao Wang
Xin Chen
Jun Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1418309

1,395 views
1 citation

Brief Research Report

Published on 27 Jun 2024

Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Alexandru Tatomir
Freidrich Anselmo
Dallas Boodhoo
Hegang Chen
Armugam P. Mekala
Vinh Nguyen
Jacob Cuevas
Violeta Rus
Horea Rus

Frontiers in Immunology

doi 10.3389/fimmu.2024.1338585

1,337 views

Editorial

Published on 19 Jun 2024

Editorial: The immune microenvironment landscape in cerebrovascular diseases

in Multiple Sclerosis and Neuroimmunology

Zhiqiang Dong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1446311

593 views

Editorial

Published on 18 Jun 2024

Editorial: Trends in neuroimmunology: cross-talk between brain-resident and peripheral immune cells in both health and disease

in Multiple Sclerosis and Neuroimmunology

Shashank K. Maurya
Janina E. Borgonovo
Suryanarayan Biswal
Verónica Martínez-Cerdeño
Rajnikant Mishra
Estela M. Muñoz

Frontiers in Immunology

doi 10.3389/fimmu.2024.1442322

1,122 views

Original Research

Published on 17 Jun 2024

Clinical features in antiglycine receptor antibody-related disease: a case report and update literature review

in Multiple Sclerosis and Neuroimmunology

Xiaoke Wu
Haifeng Zhang
Mengmeng Shi
Shaokuan Fang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1387591

1,887 views
1 citation

Original Research

Published on 13 Jun 2024

Corticosteroid-depending effects on peripheral immune cell subsets vary according to disease modifying strategies in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Lena Höpner
Undine Proschmann
Hernan Inojosa
Tjalf Ziemssen
Katja Akgün

Frontiers in Immunology

doi 10.3389/fimmu.2024.1404316

1,348 views

Original Research

Published on 12 Jun 2024

Single-cell profiling indicates a high similarity between immune cells in the cerebrospinal fluid and in meningeal ectopic lymphoid tissue in experimental autoimmune encephalomyelitis

in Multiple Sclerosis and Neuroimmunology

Tanya Georgieva
Jolien Diddens
Verena Friedrich
Gildas Lepennetier
Rosa Margareta Brand
Klaus Lehmann-Horn

Frontiers in Immunology

doi 10.3389/fimmu.2024.1400641

1,559 views

Original Research

Published on 11 Jun 2024

Elucidating sleep disorders: a comprehensive bioinformatics analysis of functional gene sets and hub genes

in Multiple Sclerosis and Neuroimmunology

Junhan Lin
Changyuan Liu
Ende Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1381765

1,692 views

General Commentary

Published on 11 Jun 2024

Commentary: Mesenchymal stem cells in the treatment of spinal cord injury: mechanisms, current advances and future challenges

in Multiple Sclerosis and Neuroimmunology

Sabino Luzzi
Antonio Crovace
Alberto M. Crovace

Frontiers in Immunology

doi 10.3389/fimmu.2024.1354118

721 views

Review

Published on 11 Jun 2024

Exposing the latent phenotype of Gulf War Illness: examination of the mechanistic mediators of cognitive dysfunction

in Multiple Sclerosis and Neuroimmunology

Hannah E. Burzynski
Lawrence P. Reagan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1403574

947 views

Brief Research Report

Published on 10 Jun 2024

Albumin and multiple sclerosis: a prospective study from UK Biobank

in Multiple Sclerosis and Neuroimmunology

Ke Chen
Chunyu Li
Bi Zhao
Huifang Shang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1415160

1,411 views
1 citation

Original Research

Published on 10 Jun 2024

Unveiling Immune-related feature genes for Alzheimer’s disease based on machine learning

in Multiple Sclerosis and Neuroimmunology

Guimei Zhang
Shuo Sun
Yingying Wang
Yang Zhao
Li Sun

Frontiers in Immunology

doi 10.3389/fimmu.2024.1333666

1,303 views

Original Research

Published on 07 Jun 2024

A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression

in Multiple Sclerosis and Neuroimmunology

Maria Inmaculada Dominguez-Mozo
Victoria Galán
Lluís Ramió-Torrentà
Ana Quiroga
E. Quintana
Luisa María Villar
Lucienne Costa-Frossard
José Ignacio Fernández-Velasco
Noelia Villarrubia
María Angel Garcia-Martinez

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384411

1,204 views

Navigation group

Articles

Potential value and research frontiers of virus in neuroinflammation: a bibliometric and visualized analysis

Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)

The levels of circulating cytokines and risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study

Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosis

Editorial: The immune microenvironment landscape in cerebrovascular diseases

Editorial: Trends in neuroimmunology: cross-talk between brain-resident and peripheral immune cells in both health and disease

Clinical features in antiglycine receptor antibody-related disease: a case report and update literature review

Corticosteroid-depending effects on peripheral immune cell subsets vary according to disease modifying strategies in multiple sclerosis

Single-cell profiling indicates a high similarity between immune cells in the cerebrospinal fluid and in meningeal ectopic lymphoid tissue in experimental autoimmune encephalomyelitis

Elucidating sleep disorders: a comprehensive bioinformatics analysis of functional gene sets and hub genes

Commentary: Mesenchymal stem cells in the treatment of spinal cord injury: mechanisms, current advances and future challenges

Exposing the latent phenotype of Gulf War Illness: examination of the mechanistic mediators of cognitive dysfunction

Albumin and multiple sclerosis: a prospective study from UK Biobank

Unveiling Immune-related feature genes for Alzheimer’s disease based on machine learning

A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression